Pyrazinamide: An Essential Drug in the Tuberculosis Treatment

被引：11

作者：

da Silva Lima, Camilo H.

Ferreira Bispo, Marcelle de L.

de Souza, Marcus Vinicius N. ^{[1
]}

机构：

[1] Fundacao Oswaldo Cruz, Inst Tecnol Farmcos Far Manguinhos, R Sizenando Nabuco 100, BR-21041250 Rio De Janeiro, RJ, Brazil

来源：

REVISTA VIRTUAL DE QUIMICA | 2011年 / 3卷 / 03期

关键词：

pyrazinamide; tuberculosis; drugs;

D O I：

10.5935/1984-6835.20110021

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Pyrazinamide (PZA) is an important drug used against tuberculosis that helped to decrease the time of treatment from twelve to six months. The main action of this drug is the elimination of dormant bacilli, which are responsible for the emergence of resistant strains. However, few analogs have been synthesized with the purpose to explore and develop new compounds more effective and selective against M. tuberculosis. In this context, this review aims to highlight the importance of PZA in the treatment of tuberculosis as well as the development of new substances based on this drug with potential antimycobacterial activities.

引用

页码：159 / 180

页数：22

共 56 条

[1] Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach [J].

Banfi, Elena ;

Scialino, Giuditta ;

Zampieri, Daniele ;

Mamolo, Maria Grazia ;

Vio, Luciano ;

Ferrone, Marco ;

Fermeglia, Maurizio ;

Paneni, Maria Silvia ;

Pricl, Sabrina .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (01) :76-84

[2] Characterization and catalytic properties of the sterol 14α-demethylase from Mycobacterium tuberculosis [J].

Bellamine, A ;

Mangla, AT ;

Nes, WD ;

Waterman, MR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :8937-8942

[3] Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters [J].

Bergmann, KE ;

Cynamon, MH ;

Welch, JT .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (17) :3394-3400

[4]

Bhat VT, 2010, NAT CHEM, V2, P490, DOI [10.1038/nchem.658, 10.1038/NCHEM.658]

[5]

Bispo M. F. L., 2011, J HETEROCYCL CHEM

[6]

BRAVO TC, 1975, TUBERCLE, V56, P211

[7] The evolution of mycobacterial pathogenicity: clues from comparative genomics [J].

Brosch, R ;

Pym, AS ;

Gordon, SV ;

Cole, ST .

TRENDS IN MICROBIOLOGY, 2001, 9 (09) :452-458

[8] Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethytene pyrazinamide anatogs [J].

Chung, Woo Jin ;

Kornilov, Andrei ;

Brodsky, Benjamin H. ;

Higgins, Michael ;

Sanchez, Tracy ;

Heifets, Leonid B. ;

Cynamon, Michael H. ;

Welch, John .

TUBERCULOSIS, 2008, 88 (05) :410-419

[9]

Cynamon MH, 1998, ANTIMICROB AGENTS CH, V42, P462

[10] ANTIMYCOBACTERIAL ACTIVITY OF A SERIES OF PYRAZINOIC ACID-ESTERS [J].

CYNAMON, MH ;

KLEMENS, SP ;

CHOU, TS ;

GIMI, RH ;

WELCH, JT .

JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (07) :1212-1215

← 1 2 3 4 5 6 →